Zhang et al. indicated that decreasing Ezrin expression significantly inhibited cell proliferation, mobility, and invasiveness in hepatocellular carcinoma cell lines, and that Ezrin enhanced the growth of cancer cells by supporting cell division and cell cycle progression from G0/G1 to S and G2/M phases [36]. This evidence concerns the gene EZR and hepatocellular carcinoma.